The neurotoxic profile of (2S,4R,6E)-2-amino-4-carboxy-7-(2-naphthyl)hept-6
-enoic acid (LY339434), a low-affinity kainate receptor subtype 5 (GluR5) a
gonist at recombinant human glutamate receptors, was evaluated to investiga
te the involvement of GluR5 in excitotoxic neuronal death. Murine cortical
neurons were exposed to treatments for 24 h and assessed by a cell viabilit
y assay and phase-contrast microscopy. LY339434 (1-1000 mu M) caused a conc
entration-dependent decrease in cell viability (EC50 = 11.4+/-1.2 mu M) tha
t was only attenuated by (5R,10S)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d
]cyclohepten-5, 10-imine (MK-801, 10 mu M), but not by 6-cyano-7-nitroquino
xaline-2,3-dione (CNQX; 50 mu M) or 1-(4-aminophenyl)-4-methyl-7,8-methylen
edioxy-5H-2,3-benzodiazepine (GYKI 52466, 20 mu M). Labeling with nucleic a
cid binding dyes revealed that LY339434 induced few apoptotic-like characte
ristics. These findings indicate that in cultured murine cortical neurons,
LY339434 acts predominantly through N-methyl-D-aspartate (NMDA) receptors r
ather than GluR5 to effect neuronal death that is rapid and involves predom
inantly necrosis rather than morphological apoptosis. (C) 2000 Elsevier Sci
ence B.V. All rights reserved.